All patients with positive test results will receive a phone call directly from their Kinney pharmacist within 3-5 days. All patients with negative test results will receive an email from a Kinney Drugs representative within 3-5 days and will NOT receive a direct phone call.
Kinney Drugs has partnered with the University of Vermont (UVM) to offer COVID-19 screenings at various locations in Vermont. Please note, this is not a serology/antibody test, and will not tell you if you were sick with COVID-19 in the past. This test site is for testing asymptomatic community members for the COVID-19 virus.
Before scheduling an appointment, consider the following questions:
1. Do you currently have symptoms of COVID-19 (fever, cough and shortness of breath, chills, repeated shaking with chills, muscle pain, headache, sore throat, new loss of taste or smell)?
2. Have you been contact with anyone who has testing positive for COVID-19 in the past few days?
3. Is the person seeking testing under the age of 2?
If you have answered yes to either of those questions, please stop here. You will need to reach out to your primary care provider or call 2-1-1 (if you do not have a primary care provider) for next steps. Community pop-up testing sites like Kinney’s only test individuals who have a low risk for being positive for COVID-19.
To schedule an appointment, please click your preferred location below. Once you have registered you will receive a reminder the day before your appointment.
Saturday, April 25th, 2020, Gov. Andrew Cuomo signed an Executive Order (EO) granting NYS pharmacists the ability to order and perform CLIA-waived COVID-19 diagnostic and antibody testing. Previously, pharmacists were not authorized to perform CLIA-waived tests in NY without an order from a physician or nurse practitioner. The new Executive Order removed this barrier for COVID-19 diagnostic and antibody testing. A diagnostic test is performed on a patient who meets specific criteria to ascertain if the patient is currently infected with the COVID-19 virus. An antibody test is performed to ascertain if a patient has had a COVID-19 infection in the past. Diagnostic testing requires a high level of personal protective equipment (PPE) and should be provided outside of the retail pharmacy, in a drive-thru type setting. Antibody testing can typically be offered in a routine pharmacy setting.
Kinney Drugs is actively assessing our ability to provide both diagnostic and antibody testing. The company is in the process of developing a plan, which includes sourcing an adequate supply of test kits and personal protective equipment (PPE), training staff, preparing and staffing testing sites, and documenting proper workflow and procedures. Kinney is engaging with partners at the state level as part of this process and will keep the public updated when testing can be made available.
“Kinney’s top priority has always been the health and safety of our patients and employees. We are happy that pharmacists have been called upon to take a significant role in the COVID-19 pandemic. We recognize the importance of testing in curtailing the spread of coronavirus,” said Rebecca Bubel, R.Ph., President of Kinney Drugs. “We’d like to assure everyone that our pharmacy teams are working very hard to rise to this challenge and will provide more information on testing as soon as we possibly can."